“Health Economic Implications of Irbesartan Plus Conventional Antihypertensive Medications Versus Conventional Blood Pressure Control Alone in Patierns With Type 2 Diabetes, Hypertension, and Renal Disease in Switzerland”. Swiss Medical Weekly, vol. 136, no. 2122, May 2006, pp. 346-, https://doi.org/10.57187/smw.2006.11337.